Milne Evidence-Based Clinical Supervision
Description:
Evidence-Based Clinical Supervision critiques and summarises the best available psychological evidence relating to clinical supervision, clarifying the key principles, setting out the related practice guidelines and specifying the research and practice implications.
- A best-practice guide to clinical supervision, an approach used across psychotherapy and health services where professionals meet regularly with each other to discuss casework and training issues
- Summarises the best available clinical evidence relating to clinical supervision, and relates this information to key principles with a strong applied focus, drawing out practice guidelines and implications
- Aims to motivate health professionals to practice supervision with greater enthusiasm and proficiency
- Represents the culmination of two years' intensive research on supervision and twenty years of involvement in supporting and developing supervisors
Best prices to buy, sell, or rent ISBN 9781405158497
Frequently Asked Questions about Milne Evidence-Based Clinical Supervision
You can buy the Milne Evidence-Based Clinical Supervision book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
The price for the book starts from $47.09 on Amazon and is available from 7 sellers at the moment.
If you’re interested in selling back the Milne Evidence-Based Clinical Supervision book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Milne Evidence-Based Clinical Supervision book, the best buyback offer comes from and is $ for the book in good condition.
The Milne Evidence-Based Clinical Supervision book is in very low demand now as the rank for the book is 5,350,365 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.